Copyright Reports & Markets. All rights reserved.

Global Cell Therapy and Tissue Engineering Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cell Therapy and Tissue Engineering Market Status and Forecast (2017-2028)
      • 1.3.2 Global Cell Therapy and Tissue Engineering Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cell Therapy and Tissue Engineering Supply by Company

    • 2.1 Global Cell Therapy and Tissue Engineering Sales Volume by Company
    • 2.2 Global Cell Therapy and Tissue Engineering Sales Value by Company
    • 2.3 Global Cell Therapy and Tissue Engineering Price by Company
    • 2.4 Cell Therapy and Tissue Engineering Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Cell Therapy and Tissue Engineering Market Status by Type

    • 3.1 Cell Therapy and Tissue Engineering Type Introduction
      • 3.1.1 Cell Therapy
      • 3.1.2 Tissue Engineering
    • 3.2 Global Cell Therapy and Tissue Engineering Market by Type
      • 3.2.1 Global Cell Therapy and Tissue Engineering Sales Volume by Type (2017-2022)
      • 3.2.2 Global Cell Therapy and Tissue Engineering Sales Value by Type (2017-2022)
      • 3.2.3 Global Cell Therapy and Tissue Engineering Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Cell Therapy and Tissue Engineering Market Status by Application

    • 4.1 Cell Therapy and Tissue Engineering Segment by Application
      • 4.1.1 Cell Defects
      • 4.1.2 Genetic Diseases
      • 4.1.3 Neurodegenerative Diseases
      • 4.1.4 Tissue Malignancies
      • 4.1.5 Others
    • 4.2 Global Cell Therapy and Tissue Engineering Market by Application
      • 4.2.1 Global Cell Therapy and Tissue Engineering Sales Volume by Application (2017-2022)
      • 4.2.2 Global Cell Therapy and Tissue Engineering Sales Value by Application (2017-2022)
      • 4.2.3 Global Cell Therapy and Tissue Engineering Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Cell Therapy and Tissue Engineering Market Status by Region

    • 5.1 Global Cell Therapy and Tissue Engineering Market by Region
      • 5.1.1 Global Cell Therapy and Tissue Engineering Sales Volume by Region
      • 5.1.2 Global Cell Therapy and Tissue Engineering Sales Value by Region
    • 5.2 North America Cell Therapy and Tissue Engineering Market Status
    • 5.3 Europe Cell Therapy and Tissue Engineering Market Status
    • 5.4 Asia Pacific Cell Therapy and Tissue Engineering Market Status
    • 5.5 Central & South America Cell Therapy and Tissue Engineering Market Status
    • 5.6 Middle East & Africa Cell Therapy and Tissue Engineering Market Status

    6 North America Cell Therapy and Tissue Engineering Market Status

    • 6.1 North America Cell Therapy and Tissue Engineering Market by Country
      • 6.1.1 North America Cell Therapy and Tissue Engineering Sales Volume by Country (2017-2022)
      • 6.1.2 North America Cell Therapy and Tissue Engineering Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cell Therapy and Tissue Engineering Market Status

    • 7.1 Europe Cell Therapy and Tissue Engineering Market by Country
      • 7.1.1 Europe Cell Therapy and Tissue Engineering Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Cell Therapy and Tissue Engineering Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cell Therapy and Tissue Engineering Market Status

    • 8.1 Asia Pacific Cell Therapy and Tissue Engineering Market by Country
      • 8.1.1 Asia Pacific Cell Therapy and Tissue Engineering Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Cell Therapy and Tissue Engineering Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cell Therapy and Tissue Engineering Market Status

    • 9.1 Central & South America Cell Therapy and Tissue Engineering Market by Country
      • 9.1.1 Central & South America Cell Therapy and Tissue Engineering Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Cell Therapy and Tissue Engineering Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cell Therapy and Tissue Engineering Market Status

    • 10.1 Middle East & Africa Cell Therapy and Tissue Engineering Market by Country
      • 10.1.1 Middle East & Africa Cell Therapy and Tissue Engineering Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Cell Therapy and Tissue Engineering Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Cell Therapy and Tissue Engineering Manufacturing Cost Analysis
    • 11.5 Cell Therapy and Tissue Engineering Sales Channel and Distributors Analysis
      • 11.5.1 Cell Therapy and Tissue Engineering Sales Channel
      • 11.5.2 Cell Therapy and Tissue Engineering Distributors
    • 11.6 Cell Therapy and Tissue Engineering Downstream Major Buyers

    12 Global Cell Therapy and Tissue Engineering Market Forecast by Type and by Application

    • 12.1 Global Cell Therapy and Tissue Engineering Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Cell Therapy and Tissue Engineering Forecast by Type
      • 12.2.1 Global Cell Therapy and Tissue Engineering Sales Volume Forecast by Type
      • 12.2.2 Global Cell Therapy and Tissue Engineering Sales Value Forecast by Type
      • 12.2.3 Global Cell Therapy and Tissue Engineering Price Forecast by Type
    • 12.3 Global Cell Therapy and Tissue Engineering Forecast by Application
      • 12.3.1 Global Cell Therapy and Tissue Engineering Sales Volume Forecast by Application
      • 12.3.2 Global Cell Therapy and Tissue Engineering Sales Value Forecast by Application
      • 12.3.3 Global Cell Therapy and Tissue Engineering Price Forecast by Application

    13 Global Cell Therapy and Tissue Engineering Market Forecast by Region/Country

    • 13.1 Global Cell Therapy and Tissue Engineering Market Forecast by Region (2023-2028)
      • 13.1.1 Global Cell Therapy and Tissue Engineering Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Cell Therapy and Tissue Engineering Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Wuxi App Tec, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.1.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 WindMIL Therapeutics, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.2.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Waisman Biomanufacturing
      • 14.3.1 Company Information
      • 14.3.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.3.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Voyager Therapeutics, Inc
      • 14.4.1 Company Information
      • 14.4.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.4.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Sangamo Therapeutics, Inc
      • 14.5.1 Company Information
      • 14.5.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.5.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Rubius Therapeutics, Inc.
      • 14.6.1 Company Information
      • 14.6.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.6.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 RoslinCT
      • 14.7.1 Company Information
      • 14.7.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.7.3 RoslinCT Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 RoslinCT
      • 14.8.1 Company Information
      • 14.8.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.8.3 RoslinCT Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 RoosterBio, Inc
      • 14.9.1 Company Information
      • 14.9.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.9.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 RoosterBio, Inc
      • 14.10.1 Company Information
      • 14.10.2 Cell Therapy and Tissue Engineering Product Introduction
      • 14.10.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Richter-Helm BioLogics GmbH & Co. KG
    • 14.12 Richter-Helm BioLogics GmbH & Co. KG
    • 14.13 ReNeuron Group plc
    • 14.14 ReNeuron Group plc
    • 14.15 Nohla Therapeutics, Inc
    • 14.16 NexImmune, Inc.
    • 14.17 Neuralstem, Inc
    • 14.18 NantKwest, Inc.
    • 14.19 Mustang Bio, Inc
    • 14.20 MolMed S.p.A
    • 14.21 Miromatrix Medical, Inc.
    • 14.22 Mesoblast Limited
    • 14.23 MEDIPOST CO.
    • 14.24 Medigene AG
    • 14.25 MaxCyte, Inc
    • 14.26 Brainstorm Cell Therapeutics, Inc
    • 14.27 Biosolution Co.
    • 14.28 BioReliance Corporation
    • 14.29 BioCardia, Inc
    • 14.30 Betalin Therapeutics

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Cell Therapy and Tissue Engineering market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cell Therapy and Tissue Engineering industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Cell Therapy and Tissue Engineering market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cell Therapy and Tissue Engineering Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Cell Therapy and Tissue Engineering market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Cell Therapy and Tissue Engineering Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Cell Therapy and Tissue Engineering industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Cell Therapy
      Tissue Engineering

      Segmented by Application
      Cell Defects
      Genetic Diseases
      Neurodegenerative Diseases
      Tissue Malignancies
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Waisman Biomanufacturing
      Voyager Therapeutics, Inc
      Sangamo Therapeutics, Inc
      Rubius Therapeutics, Inc.
      RoslinCT
      RoslinCT
      RoosterBio, Inc
      RoosterBio, Inc
      Richter-Helm BioLogics GmbH & Co. KG
      Richter-Helm BioLogics GmbH & Co. KG
      ReNeuron Group plc
      ReNeuron Group plc
      Nohla Therapeutics, Inc
      NexImmune, Inc.
      Neuralstem, Inc
      NantKwest, Inc.
      Mustang Bio, Inc
      MolMed S.p.A
      Miromatrix Medical, Inc.
      Mesoblast Limited
      MEDIPOST CO.
      Medigene AG
      MaxCyte, Inc
      Brainstorm Cell Therapeutics, Inc
      Biosolution Co.
      BioReliance Corporation
      BioCardia, Inc
      Betalin Therapeutics
      Buy now